首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   3934篇
  免费   286篇
  国内免费   65篇
耳鼻咽喉   97篇
儿科学   94篇
妇产科学   13篇
基础医学   88篇
口腔科学   78篇
临床医学   1044篇
内科学   224篇
皮肤病学   8篇
神经病学   27篇
特种医学   67篇
外科学   1086篇
综合类   820篇
预防医学   150篇
眼科学   132篇
药学   263篇
  7篇
中国医学   46篇
肿瘤学   41篇
  2024年   3篇
  2023年   75篇
  2022年   86篇
  2021年   145篇
  2020年   155篇
  2019年   109篇
  2018年   146篇
  2017年   153篇
  2016年   124篇
  2015年   148篇
  2014年   299篇
  2013年   302篇
  2012年   287篇
  2011年   292篇
  2010年   243篇
  2009年   182篇
  2008年   146篇
  2007年   175篇
  2006年   157篇
  2005年   134篇
  2004年   124篇
  2003年   89篇
  2002年   91篇
  2001年   70篇
  2000年   65篇
  1999年   49篇
  1998年   39篇
  1997年   42篇
  1996年   34篇
  1995年   50篇
  1994年   52篇
  1993年   24篇
  1992年   21篇
  1991年   27篇
  1990年   22篇
  1989年   13篇
  1988年   13篇
  1987年   15篇
  1986年   8篇
  1985年   13篇
  1984年   21篇
  1983年   11篇
  1982年   6篇
  1981年   5篇
  1980年   10篇
  1978年   3篇
  1977年   4篇
  1975年   1篇
  1973年   1篇
  1972年   1篇
排序方式: 共有4285条查询结果,搜索用时 31 毫秒
101.
Objective: This network meta-analysis (NMA) aimed to determine the relative efficacy and safety of pharmacological strategies used to mitigate haemodynamic instability by intubation for general anaesthesia in hypertensive parturient women undergoing caesarean section.Methods: We considered randomised controlled studies comparing the effects of pharmacological strategies used to alleviate haemodynamic instability during intubation in parturient women with hypertensive disorders of pregnancy. The primary endpoints were maximum blood pressure and heart rate after intubation, and secondary endpoints were the Apgar scores at 1 and 5 min. NMA allowed us to combine direct and indirect comparisons between strategies.Results: Twelve studies evaluating nine pharmacological strategies in 619 patients were included. According to the surface under the cumulative ranking curve, the maximal mean arterial pressure was lowest for high-dose remifentanil (99.4%) followed by nitroglycerin (73.6%) and labetalol (60.9%). The maximal heart rate was lowest for labetalol (99.9%) followed by high dose of remifentanil (81.2%) and fentanyl (61.6%). Apgar score at 1 min was higher with low-dose than with high-dose remifentanil (mean difference, 0.726; 95% confidence interval, 0.056 to 1.396; I2=0.0%).Conclusions: High-dose remifentanil produces minimum blood pressure changes, while labetalol is most effective in maintaining normal heart rate in parturient women with hypertensive disorders of pregnancy during caesarean section under general anaesthesia.  相似文献   
102.
103.
We reviewed the literature on obstetric failed tracheal intubation from 1970 onwards. The incidence remained unchanged over the period at 2.6 (95% CI 2.0 to 3.2) per 1000 anaesthetics (1 in 390) for obstetric general anaesthesia and 2.3 (95% CI 1.7 to 2.9) per 1000 general anaesthetics (1 in 443) for caesarean section. Maternal mortality from failed intubation was 2.3 (95% CI 0.3 to 8.2) per 100 000 general anaesthetics for caesarean section (one death per 90 failed intubations). Maternal deaths occurred from aspiration or hypoxaemia secondary to airway obstruction or oesophageal intubation. There were 3.4 (95% CI 0.7 to 9.9) front-of-neck airway access procedures (surgical airway) per 100 000 general anaesthetics for caesarean section (one procedure per 60 failed intubations), usually carried out as a late rescue attempt with poor maternal outcomes. Before the late 1990s, most cases were awakened after failed intubation; since the late 1990s, general anaesthesia has been continued in the majority of cases. When general anaesthesia was continued, a laryngeal mask was usually used but with a trend towards use of a second-generation supraglottic airway device. A prospective study of obstetric general anaesthesia found that transient maternal hypoxaemia occurred in over two-thirds of cases of failed intubation, usually without sequelae. Pulmonary aspiration occurred in 8% but the rate of maternal intensive care unit admission after failed intubation was the same as that after uneventful general anaesthesia. Poor neonatal outcomes were often associated with preoperative fetal compromise, although failed intubation and lowest maternal oxygen saturation were independent predictors of neonatal intensive care unit admission.  相似文献   
104.
AimTo compare the first-attempt success in endotracheal intubation (ETI) during cardiopulmonary resuscitation (CPR) using direct laryngoscopy (DL) and video laryngoscopy (VL) (GlideScope®) among novice emergency physicians (EPs).MethodsThis study is a historically controlled clinical design. From May 2011 to April 2013 out-of-hospital cardiac arrest patients were intubated during CPR by novice EPs. CPR data was automatically recorded by pre-installed video and subsequently analysed. The primary outcome was the success rate of the first-attempt at ETI. In addition, time to successful ETI from first-attempt (T-complete), duration of chest compression interruptions, and incidence of oesophageal intubation were compared.ResultsOf 305 patients undergoing ETI, 83 were intubated by novice EPs. The success rate of first-attempt ETI in the VL group (n = 49) was higher than that in the DL group (n = 34, 91.8% vs. 55.9%; p < 0.001). The median T-complete was significantly shorter with VL than with DL (37 [29–55] vs. 62 [56–110] s; p < 0.001). Oesophageal intubation was observed only in the DL group (n = 6, 17.6%). The median duration of chest compression interruptions was greater with DL (7 [3–6] s) than with VL (0 [0–0] s). Improvements in ETI during CPR were observed in the VL group after the first 3 months, but not the DL group during regular use for 1 year.ConclusionsFor novice EPs, the VL could significantly improve the first-attempt success in ETI during CPR while the DL couldn’t improve it.  相似文献   
105.
目的:观察舒芬太尼用于高龄患者全麻诱导气管插管的临床效果。方法选择ASAⅡ~Ⅲ级,需在气管插管全身麻醉下行四肢手术的高龄(年龄≥80岁)患者45例,随机分三组:舒芬太尼0.15μg/kg 组( S1组)、舒芬太尼0.25μg/kg组(S2组)及芬太尼2μg/kg组(F组),每组15例。所有患者均分别记录基础值(T0)、插管前1 min(T1)、插管后1 min(T2)和插管后5 min(T3)的收缩压(SP)、舒张压(DP)和心率(HR),并计算各时间点 SP 与 HR 的乘积( RPP);记录不良反应的发生及药物使用情况。结果三组T1时间点BP和T3时间点SP、S2组T2时间点SP和F组T3时间点DP均显著低于同组T0时间点(P均<0.01),F组T2时间点DP显著高于同组T0时间点(P<0.05)和S2组同时间点( P<0.05),S1组和S2组T1时间点SP、S2组T2时间点BP均显著低于F组同时间点( P<0.01或0.05)。S1组和F组T2时间点HR均显著大于同组T0时间点( P均<0.01)和S2组同时间点( P<0.05)。三组T1、T3时间点RPP均显著小于同组T0时间点( P<0.01或0.05)。F组T2时间点RPP显著大于同组T0时间点( P<0.05)和S2组同时间点(P<0.05)。S2组声带活动发生率、丙泊酚和瑞芬太尼使用率小于S1组,罗库溴铵、新福林使用率均显著小于S1组和F组(P<0.05)。结论舒芬太尼0.25μg/kg用于高龄患者全麻诱导,不仅能抑制插管反应,减少不良反应,而且能保持插管前后心血管功能稳定和心肌氧供需平稳,安全可行。  相似文献   
106.
目的:比较光棒联合新型喉罩气管插管与纤维支气管镜气管插管的临床效果。方法选择100例接受光棒联合新型喉罩气管插管全身麻醉的患者100例为观察组,同期接受纤维支气管镜气管插管患者100例为对照组。观察两组不同等级气道插管情况( Mallampati分级Ⅰ~Ⅳ级)及置管成功前后血流动力学变化,包括平均动脉压、血氧饱和度、心率、呼气末二氧化碳分压。比较两组插管时间及并发症发生情况。结果观察组Ⅳ级气道插管成功率为80.0%,显著高于对照组的36.4%,气管插管时间短于对照组,差异均有统计学意义( P<0.05)。气管插管置入后,观察组平均动脉压、心率、咽喉疼痛及口腔损伤的比例均低于对照组,差异有统计学意义( P<0.05)。两组血氧饱和度、呼气末二氧化碳分压比较差异均无统计学意义( P>0.05)。结论光棒联合新型喉罩气管插管成功率高,对血流动力学影响小,并发症少,值得临床推广应用。  相似文献   
107.
目的探讨气管插管患者口腔护理的有效方法,提高护理质量,减少并发症的发生。方法采用对照研究的方式,将2013年1月至2014年6月间我院ICU收治的60例气管插管患者随机分为观察组和对照组,观察组施行负压式牙刷刷牙法,对照组施行常规口腔护理法。比较两组患者护理前后口腔细菌检测情况、口腔症状、pH值、呼吸机相关性肺炎、意外脱管、机械通气的时间以及患者的舒适度。结果观察组护理后即刻的细菌数、护理后2h、4h、6h的细菌数均少于对照组,5d牙菌斑率、口腔细菌阳性率均低于对照组,差异有统计学意义( P<0.05)。观察组护理后的口腔溃疡、疱疹、口臭、呼吸机相关性肺炎的发生率低于对照组,护理5 d时的口腔pH值高于对照组,机械通气时间短于对照组,差异有统计学意义( P<0.05)。两组的舒适度差异无统计学意义( P>0.05)。结论带负压式牙刷刷牙法能够有效清除气管插管患者的口腔细菌,预防感染的发生,优于传统的口腔护理方法。  相似文献   
108.
109.
110.
目的 观察双腔气管导管(double-lumen endotracheal tube,DLT)塑型对插管成功率及术后声音嘶哑(声嘶)、咽喉痛的影响,从而为寻求更好的DLT塑型插管提供依据. 方法 择期全身麻醉下行胸科手术患者160例,美国麻醉医师协会(ASA)分级Ⅰ~Ⅲ级,参照随机数字表法分成DLT插管塑型组和非塑型组(每组80例),两组根据左右DLT插管各分为两组(A、B、C、D组,每组40例),又根据性别再各分为两个亚组(A1、A2、B1、B2、C1、C2、D1、D2组,每组20例).两组均采用经口明视气管插管,塑型组采用塑成“J”状的DLT进行插管,非塑型组采用未经塑型保留原有弯度的DLT进行插管.观察DLT插管时间、插管尝试次数及插反情况,患者术后声嘶、咽喉痛发生率及严重程度. 结果 塑型组插管时间[(154±6)s]明显短于非塑型组[(185±13)s](P<0.05);塑型组插管尝试次数[(1.4±0.4)次]明显少于非塑型组[(1.7±0.8)次](P<0.05);塑型组插反情况(3次)明显比非塑型组少(11次)(P<0.05),且与性别无关,但左DLT比右DLT易于插反(P<0.05).患者术后声嘶发生率塑型组(15/80)明显低于非塑型组(33/80)(P<0.05);患者术后咽喉痛发生率塑型组(15/80)明显低于非塑型组(31/80) (P<0.05),且与性别有关,女性较男性术后易发生声嘶、咽喉痛. 结论 “J”状DLT塑型插管成功率高、刺激小,可降低患者术后声嘶、咽喉痛发生率,具有一定的临床推广意义.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号